Income StatementBalance SheetCash FlowSegments
United Therapeutics logo

United Therapeutics Balance Sheet Statement

Assets, liabilities, and shareholders' equity

United Therapeutics holds $6.7B in total assets. Cash and equivalents total $1.3B. The current ratio is 4.79. Based on the Q1 2026 filing.

Total Assets$6.7BTotal Stockholders Equity$5.9BCash And Equivalents$1.3BTotal Current Assets$2.9BTotal Current Liabilities$599.1M
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$24.1B
P/E Ratio18.69
ROE20.26%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$344.5M$367.0M$432.0M$468.0M$488.0M$498.3M
Accounts payable and other current liabilities (Note 11)$344.5M$367.0M$432.0M$468.0M$488.0M$498.3M
Other accrued liabilities$93.6M$154.5M$95.1M$78.3M$72.6M$100.8M
Note payable to DIRECTV$82.6M$154.5M$95.1M$78.3M$72.6M$100.8M
Total current liabilities$738.1M$721.5M$527.1M$546.3M$560.6M$599.1M

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$279.3M$322.0M$379.3M$297.7M$350.2M$312.0M
Cash and cash equivalents$1.7B$1.9B$1.6B$1.3B$1.6B$1.3B
Short- term Investments$1.6B$1.4B$1.5B$1.4B$1.4B$874.0M
Other current assets$169.7M$131.1M$229.7M$252.2M$248.9M$228.0M
Inventories$157.9M$165.4M$169.2M$176.5M$183.1M$178.3M
Prepaid expenses and other current assets$169.7M$131.1M$229.7M$252.2M$248.9M$228.0M
Short-term investments$1.6B$1.4B$1.5B$1.4B$1.4B$874.0M
Total current assets$3.9B$3.9B$3.8B$3.5B$3.7B$2.9B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$2.7B$2.7B$2.8B$2.7B$2.8B$2.5B
Accumulated other comprehensive income (loss)-$3.4M-$1.2M$0.0$100.0K$900.0K-$10.2M
Common stock$800.0K$800.0K$800.0K$800.0K$800.0K$800.0K
Additional paid-in capital$2.7B$2.7B$2.8B$2.7B$2.8B$2.5B
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$800.0K$800.0K$800.0K$800.0K$800.0K$800.0K
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Preferred stock$0.0$0.0$0.0$0.0$0.0$0.0
Retained earnings$7.2B$7.5B$7.9B$8.2B$8.6B$8.8B
Total liabilities and stockholders' equity$7.4B$7.7B$7.9B$7.4B$7.9B$6.7B
Total stockholders' equity$6.4B$6.8B$7.2B$6.6B$7.1B$5.9B
Treasury stock$3.5B$3.5B$3.5B$4.3B$4.3B$5.4B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred tax assets$458.4M$456.6M$456.2M$354.9M$357.7M$335.4M
Deferred Tax Assets and Other Non-Current Assets$222.1M$222.4M$233.3M$262.6M$196.9M$233.2M
Goodwill$111.9M$111.7M$111.5M$116.7M$116.5M$115.5M
Goodwill and Intangible Assets, Net$111.9M$111.7M$111.5M$116.7M$116.5M$115.5M
Deferred tax assets$458.4M$456.6M$456.2M$354.9M$357.7M$335.4M
Goodwill and intangible assets, net$111.9M$111.7M$111.5M$116.7M$116.5M$115.5M
Other non-current assets$222.1M$222.4M$233.3M$262.6M$196.9M$233.2M
Other non-current assets$222.1M$222.4M$233.3M$262.6M$196.9M$233.2M
Property and equipment, net$1.2B$1.3B$1.4B$1.6B$1.7B$1.8B
Software and Technology Licenses, Net$222.1M$222.4M$233.3M$262.6M$196.9M$233.2M
Total assets$7.4B$7.7B$7.9B$7.4B$7.9B$6.7B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-current liabilities$181.9M$215.2M$207.3M$214.6M$223.2M$214.0M
Total liabilities$920.0M$936.7M$734.4M$760.9M$783.8M$813.1M